Crexendo (CXDO) reported $16.55 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 12.7%. EPS of $0.09 for the same period compares to $0.07 a year ago.
The reported revenue represents a surprise of +2.2% over the Zacks Consensus Estimate of $16.2 million. With the consensus EPS estimate being $0.06, the EPS surprise was +50%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Crexendo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Service: $8.37 million versus $8.23 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.
- Revenue- Product: $1.2 million versus the two-analyst average estimate of $1.13 million. The reported number represents a year-over-year change of -7%.
- Revenue- Software solutions: $6.98 million versus the two-analyst average estimate of $6.82 million. The reported number represents a year-over-year change of +31%.
View all Key Company Metrics for Crexendo here>>>
Shares of Crexendo have returned -8.1% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Crexendo Inc. (CXDO): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
